Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy.
Zoja C, Locatelli M, Corna D, Villa S, Rottoli D, Nava V, Verde R, Piscitelli F, Di Marzo V, Fingerle J, Adam JM, Rothenhaeusler B, Ottaviani G, Bénardeau A, Abbate M, Remuzzi G, Benigni A.
Zoja C, et al. Among authors: verde r.
Nephron. 2016;132(1):59-69. doi: 10.1159/000442679. Epub 2015 Dec 9.
Nephron. 2016.
PMID: 26646377